Search
Now showing items 1-10 of 10
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)
Philippen, Angela et al. (2010)
Wissenschaftlicher Artikel
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
Zenz, Thorsten et al. (2010)
Wissenschaftlicher Artikel
From pathogenesis to treatment of chronic lymphocytic leukaemia
Zenz, Thorsten et al. (2010)
Wissenschaftlicher Artikel
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia
Kienle, Dirk et al. (2010)
Wissenschaftlicher Artikel
Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
Idler, Irina et al. (2010)
Wissenschaftlicher Artikel
High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay
Bhattacharya, Nupur et al. (2010)
Wissenschaftlicher Artikel
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Zenz, Thorsten et al. (2010)
Wissenschaftlicher Artikel
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk
Winkler, Dirk et al. (2010)
Wissenschaftlicher Artikel
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
Seiffert, Martina et al. (2010)
Wissenschaftlicher Artikel
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Dreger, Peter et al. (2010)
Wissenschaftlicher Artikel